| Recruiting | 1/2 | 80 | RoW | TQB3454 Tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Acute Myeloid Leukemia, Myelodysplastic Syndromes | 06/25 | 12/25 | | |
| Active, not recruiting | 1/2 | 121 | RoW | CAR-BCMA T Cells | CARsgen Therapeutics Co., Ltd., Beijing Chao Yang Hospital, The First Affiliated Hospital of Soochow University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Tianjin Medical University General Hospital, First Affiliated Hospital of Zhejiang University, Beijing Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, First Affiliated Hospital of Wenzhou Medical University, Xiangya Hospital of Central South University, Peking University People's Hospital, Qilu Hospital of Shandong University, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University | Multiple Myeloma | 12/24 | 12/25 | | |
NCT03380039: Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma |
|
|
| Active, not recruiting | N/A | 6 | RoW | CAR-BCMA T cells, BCMA-redirected autologous T cells, Fludarabine, Cyclophosphamide | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, CARsgen Therapeutics Co., Ltd. | Refractory or Relapsed Multiple Myeloma | 07/20 | 07/23 | | |
